通过计算建模预测受体遗传变异中的催产素结合动态
Preeti Dubey1, Yingye Fang1, K Lionel Tukei1
1Department of Bioengineering, University of Washington, Seattle, WA, USA.
npj women's health
|August 29, 2025
概括
这项研究模拟了催产素受体 (OXT) 遗传变异如何影响药物反应. 数学模型为孕妇提供个性化Pitocin剂量的框架.
科学领域:
- 药物基因组学
- 分子药理学
- 计算生物学
背景情况:
- 皮托辛 (合成氧化) 是广泛使用的,但由于患者的变化,最佳剂量是困难的.
- 催产素受体 (OXTR) 的遗传变异可能会影响个体对催产素的反应.
- 了解这些遗传影响对于改善产科护理至关重要.
研究的目的:
- 开发一个模拟催产素 (OXT) 和催产素受体 (OXTR) 结合动态的数学模型.
- 研究五种特定的OXTR基因变异对OXT-OXTR相互作用的影响.
- 探索这些变异如何影响不同细胞类型的OXT反应.
主要方法:
- 开发了OXT-OXTR结合动态的数学模型.
- 包含经过实验测量的细胞特异性OXTR表面定位数据.
- 用文献报告的OXT-OXTR结合动力学进行模型参数化.
- 在人类胚胎 (HEK293T) 和宫平滑肌细胞中模拟的OXT- OXTR相互作用.
主要成果:
- 该模型确定了HEK293T和肌肉细胞之间的OXT-OXTR结合平衡时间的差异.
- 在五种研究的OXTR基因变异中观察到不同的结合动态.
- 早期使用OXT可以缓解V281M和E339K变异的反应.
结论:
- 在OXTR的基因变异显著影响OXT的剂量反应关系.
- 开发的数学模型提供了基因层面的OXT药学动力学见解.
- 这种框架可能会根据患者的遗传特征指导个性化Pitocin剂量策略.
相关概念视频
Physiological Pharmacokinetic Models: Assumption with Protein Binding
91
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
91
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
Conserved Binding Sites
4.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.3K
The Equilibrium Binding Constant and Binding Strength
13.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.4K
Ligand Binding Sites
13.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.1K
Protein-Drug Binding: Mechanism and Kinetics
924
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
924


